Skip to main content

Biocept, Inc. (BIOC)

NASDAQ: BIOC · IEX Real-Time Price · USD
1.40
-0.02 (-1.41%)
At close: Sep 22, 2023, 4:00 PM
1.34
-0.06 (-4.29%)
Pre-market: Sep 25, 2023, 8:00 AM EDT

Biocept Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Biocept.

Analyst Consensus: Hold
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

According to 1 stock analyst, the rating for Biocept is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Jul '23Aug '23Sep '23
Strong Buy 000
Buy 000
Hold 111
Sell 000
Strong Sell 000
Total 111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Jason McCarthy
Maxim Group
 Maxim Group
Hold
Downgrades
n/a
 Hold Downgrades n/a n/a Apr 14, 2023
Keay Nakae
Chardan Capital
 Chardan Capital
Strong Buy
Initiates
$22,500
 Strong Buy Initiates $22,500 +1,607,042.86% Jun 2, 2017
Full Analyst Rating History

Financial Forecast

Revenue This Year
2.53M
from 25.86M
Decreased by -90.23%
Revenue Next Year
6.60M
from 2.53M
Increased by 161.32%
EPS This Year
-5.66
from -56.70
EPS Next Year
-1.41
from -5.66
Year 20182019202020212022202320242025
Revenue
3.25M5.53M27.46M61.25M25.86M2.53M6.60M21.91M
Revenue Growth
-35.87%
70.09%
396.71%
123.04%
-57.78%
-90.23%
161.32%
231.86%
EPS
-2,703.00-366.90-45.00-5.70-56.70-5.66-1.41-0.87
EPS Growth
--------
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202320242025
High 2.6M 6.8M 22.6M
Avg 2.5M 6.6M 21.9M
Low 2.4M 6.3M 21.0M

Revenue Growth

Revenue Growth 202320242025
High
-89.9%
169.0%
241.6%
Avg
-90.2%
161.3%
231.9%
Low
-90.6%
151.1%
218.8%

EPS Forecast

EPS 202320242025
High -5.83 -1.45 -0.89
Avg -5.66 -1.41 -0.87
Low -5.44 -1.35 -0.83

EPS Growth

EPS Growth 202320242025
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.